Back

Is sacubitril/valsartan useful in patients with cancer and heart failure? Data from HF-COH spanish multicenter registry

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Cardio-oncology II Cardio-Oncology ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Ana Martin Garcia

UNIVERSITY HOSPITAL CLINIC OF SALAMANCA (COMPLEJO ASISTENCIAL UNIV.SA), Salamanca (Spain)

9 More presentations in this session

Presentation thumbnail
The clinical value of CMR in the management of Cardio-Oncology patients - a tertiary centre experience.
Doctor J. Chong (Singapore, SG)
Abstract Slides
Presentation thumbnail
Acute Myocardial Infarction in patients with Leukaemia: A national analysis of prevalence, predictors and outcomes in United States hospitalisations (2004 to 2014)
Doctor M. Mohamed (London, GB)
Abstract Slides
Presentation thumbnail
Radiotherapy-induced malfunction in cancer patients with cardiac implantable electronic devices
Doctor J. Imberti (Modena, IT)
Abstract Slides
Presentation thumbnail
Cardiovascular adverse events associated with BRAF and MEK inhibitors
Associate Professor R. Mincu (Essen, DE)
Abstract Slides
Presentation thumbnail
Long-term outcomes in patients with cancer undergoing percutaneous coronary intervention: analysis from a Japan multicenter registry
Doctor A. Endo (Tokyo, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Cardio-oncology II

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources